---
title: "Zenas BioPharma grants 100,000 stock options, 78,075 RSUs to new hires under 2026 inducement plan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290100446.md"
description: "Zenas BioPharma granted inducement equity awards to new hires under its 2026 plan. The package includes 100,000 stock options with a $18.71 exercise price and 78,075 Restricted Stock Units (RSUs). Options vest over four years, while RSUs vest in equal tranches from 2027 to 2030, subject to continued service."
datetime: "2026-06-17T20:15:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290100446.md)
  - [en](https://longbridge.com/en/news/290100446.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290100446.md)
generator: "portal-rs"
---

# Zenas BioPharma grants 100,000 stock options, 78,075 RSUs to new hires under 2026 inducement plan

-   Zenas BioPharma granted inducement equity awards dated June 15, 2026 to newly hired employees: stock options for 100,000 shares, RSUs for 78,075 shares. \* Options carry a 10-year term, $18.71 exercise price, vesting over four years with 25% after one year, then monthly installments. \* RSUs vest in four equal tranches on June 15 of 2027 through 2030, subject to continued service. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zenas Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606171615PRIMZONEFULLFEED9748607) on June 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ZBIO.US](https://longbridge.com/en/quote/ZBIO.US.md)

## Related News & Research

- [Zenas BioPharma (ZBIO) Is Down 9.2% After Wider Losses And Leadership Changes - What's Changed](https://longbridge.com/en/news/295897113.md)
- [Zenas Biopharma posts corporate presentation on autoimmune disease pipeline, led by obexelimab program](https://longbridge.com/en/news/295789100.md)
- [Here's How Much $100 Invested In Comfort Systems USA 15 Years Ago Would Be Worth Today](https://longbridge.com/en/news/296544618.md)
- [Linde director Paula Rosput Reynolds reports purchase of 100 shares valued at $47,911.5](https://longbridge.com/en/news/296390825.md)
- [Here's How Much $100 Invested In Applied Materials 15 Years Ago Would Be Worth Today](https://longbridge.com/en/news/296369921.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**